United States
Germany
Japan
United Kingdom
China
Anti-5T4 (GEN-1044 biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Primary Antibodies
Anti-GUCY2C(indusatumab biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-5T4 (H8 biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-Nectin-4(enfortumab biosimilar) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-FCRL5(cevostamab biosimilar without anti-CD3 portion) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-LILRB2 (MK-4830) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-BTN3A1(ICT 01) mAb
| Applications | FC |
| Reactivities | Human |
Anti-KLRG1(ulviprubart biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-GPRC5D(Talquetamab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-KIR2DL2(lirilumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-NKG2A(monalizumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-HTRA1(galegenimab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-CLDN18.2 (zolbetuximab biosimilar)
| Applications | FC |
| Reactivities | Human |
Anti-CCR2(plozalizumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-CGRPR(Erenumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
